-

Thomas H. Lee Partners Appoints Sam Hendler As Head of Business Development, Healthcare

Industry Veteran Will Lead Sourcing Strategy for the Firm’s Healthcare Group

BOSTON--(BUSINESS WIRE)--Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firm’s healthcare investment group. Hendler, who brings over 20 years of experience as an M&A advisor to premier middle-market companies, will lead the firm’s continued work in identifying growth opportunities across the healthcare market.

“THL continues to be a very active investor in the healthcare sector, as we partner with growth companies delivering high quality healthcare services and technology in important subsectors,” said Joshua Nelson, Managing Director and head of the firm’s Healthcare group. “Sam’s industry knowledge and strategic acumen will help THL identify the right places for investment and partnership, and allow us to continue to sharpen our focus on Identified Sector Opportunities (ISOs).”

In his new role, Hendler will join other senior leaders of the Healthcare group in developing new Identified Sector Opportunities (ISOs) for future investment and building and maintaining relationships with management teams, investors, and advisors across the healthcare market. He will also lead the group’s sourcing efforts for both new investments and current portfolio companies. The firm currently invests in five healthcare sectors: Healthcare IT, Pharmaceutical Services, Home-based Care, Consumer Healthcare, and Medtech Services.

“THL has far-reaching relationships across the healthcare industry and deep knowledge of the market,” said Hendler. “The firm’s approach to developing and focusing rigorously on identified sector opportunities has enabled it to work with companies for which it is uniquely positioned to add value. I am excited to join this outstanding team.”

Prior to joining Thomas H. Lee Partners, Hendler served as a managing director at Harris Williams, where he established and managed the firm’s global healthcare IT practice. Earlier in his career, he worked as an associate with Quellos Private Capital Markets, L.P., and as a Mergers and Acquisitions Analyst with Broadview International, LLC.

About THL

Thomas H. Lee Partners, L.P. (“THL”) is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity (“ISO”) process with dedicated internal operating resources from its Strategic Resource Group (“SRG”) to transform and build great companies of lasting value in partnership with management. The Firm’s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.

Contacts

Media
Elena Connolly
Elena.connolly@edelman.com
+1 (914) 387-2730

Thomas H. Lee Partners, L.P.


Release Versions

Contacts

Media
Elena Connolly
Elena.connolly@edelman.com
+1 (914) 387-2730

More News From Thomas H. Lee Partners, L.P.

THL Partners Raises $6.35 Billion of Investable Capital for Fund X

BOSTON--(BUSINESS WIRE)--THL Partners, a premier private equity firm investing in middle-market growth companies, today announced the final close of THL Equity Fund X, L.P. (“Fund X”) with $6.35 billion in investable capital. Fund X received strong support from a diverse group of both existing and new investors, including public and corporate pension funds, sovereign wealth funds, financial institutions, and family offices across North America, Latin America, Europe, Asia, Australia, and the Mi...

Celerion Announces Majority Investment from THL Partners

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in clinical pharmacology and bioanalytical sciences, today announced a majority investment from THL Partners (“THL”), a premier private equity firm investing in middle market growth companies. The investment will support Celerion’s continued growth and innovation, including expanding its clinical and bioanalytical capabilities and advancing its work to help pharmaceutical and biotechnology partners bring new therapies to patients worldwi...

Thomas H. Lee Partners Appoints Healthcare and Employee Benefits Industry Leader Dave Guilmette as Executive Partner

BOSTON--(BUSINESS WIRE)--THL Partners (“THL”), a premier private equity firm investing in middle-market growth companies, today announced that Dave Guilmette has joined the firm as an Executive Partner in its Financial Technology & Services investment group. Guilmette brings over 40 years of experience in building, leading, and transforming global healthcare and employee benefits businesses. In his role, Guilmette will support THL’s efforts to identify, source, and grow investment opportuni...
Back to Newsroom